How low is the α/β ratio for prostate cancer?

Recently, low α/β values of 1.2 and 1.5 Gy for prostate tumors have been derived from clinical results of external beam radiotherapy and of permanent implants of 125I and 103Pd. In the analyses the contributions of tumor repopulation, and edema as a result of inserting radioactive seeds in the prost...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 57; no. 4; pp. 1116 - 1121
Main Authors Kal, Henk B, Van Gellekom, Marion P.R
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 15.11.2003
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recently, low α/β values of 1.2 and 1.5 Gy for prostate tumors have been derived from clinical results of external beam radiotherapy and of permanent implants of 125I and 103Pd. In the analyses the contributions of tumor repopulation, and edema as a result of inserting radioactive seeds in the prostate, have been ignored. In this paper we reanalyzed the clinical data and introduced the contribution of repopulation and edema. The linear quadratic–biologically effective dose model was used for reanalysis. In this model, the influence of repopulation and edema has been taken into account. The biologically effective dose was calculated as a function of α/β for 2 brachytherapy regimens with 125I and 103Pd and 2 fractionated treatments, and for different half-times for repair of sublethal damage for the brachytherapy regimens. We have found a plausible α/β value of 3.1 to 3.9 Gy, an α value of 0.1 to 0.15 Gy −1, and a half-time of repair of about 0.5 h. It seems now that the α/β value is low, 3.1–3.9 Gy, but not as low as the 1.2 and 1.5 Gy reported earlier.
ISSN:0360-3016
1879-355X
DOI:10.1016/S0360-3016(03)01455-X